Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306]

Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306]

Multiple Sclerosis and Related Disorders (2014) 3, 666 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/msard CO...

367KB Sizes 0 Downloads 18 Views

Multiple Sclerosis and Related Disorders (2014) 3, 666

Available online at www.sciencedirect.com

journal homepage: www.elsevier.com/locate/msard

CORRIGENDUM

Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306] Aravind Ganesha,n, Sabrina Apelb, Luanne Metzc, Scott Pattend a

Resident, Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9 b Resident, Division of Neurology, University of Alberta, 33 Discovery Rise SW Calgary, Alberta, Canada T3H 4N6 c Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9 d Psychiatry and Community Health, University of Calgary, 3330 Hospital Drive NW Calgary, Alberta, Canada T2N 4N1

The authors regret that an error occurred in Table 6 of the above paper. The ARR for Kampman et al (2012) was displayed as 5.02 with a NNT of 19.91; however, it should have been an ARR of 5.02 with a NNTH (i.e. NNT with a negative outcome or harm) of 19.91. This does not change any of the other conclusions or analyses in the paper. The authors would like to apologise for any inconvenience caused.

DOI of original article: http://dx.doi.org/10.1016/j.msard.2012.12.008 Correspondence to: 221 Valley Ridge Green NW, Calgary, Alberta, Canada T3B 5L6. Tel.: +1 403 309 3651, +1 403 671 5168. E-mail address: [email protected] (A. Ganesh).

n

http://dx.doi.org/10.1016/j.msard.2014.06.004 2211-0348/& 2014 Elsevier B.V. All rights reserved.